Immune checkpoint inhibitor (ICI) combination therapy compared to monotherapy in advanced solid cancer: A systematic review

Aim: To evaluate the efficacy and safety of immune checkpoint inhibitor (ICI) two-drug combination therapy in patients with advanced malignancy. Methods: We searched PubMed, PMC, EMBASE, EBSCO, Cochrane Central Register of Controlled Trials (CENTRAL), American Society of Clinical Oncology (ASCO and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Xiaoting, Zhang, Yujian, Wang, Shan, Wei, Huamin, Yu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847663/
https://www.ncbi.nlm.nih.gov/pubmed/33531977
http://dx.doi.org/10.7150/jca.49174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847663/
https://www.ncbi.nlm.nih.gov/pubmed/33531977
http://dx.doi.org/10.7150/jca.49174

Ejemplares similares